The Polymerase Chain Reaction (PCR) Market is set to grow from USD 11.52 billion in 2025 to USD 16.49 billion by 2030, registering a 7.43% CAGR.
Polymerase chain reaction, or PCR, is a technique to make many copies of a specific DNA region in vitro and relies on a thermostable DNA polymerase, Taq polymerase, and requires DNA primers designed specifically for the DNA region of interest. Using PCR it is possible to generate thousands to millions of copies of a particular section of DNA from a very small amount of DNA and is a common tool that is routinely used in DNA cloning, medical diagnostics, and forensic analysis of DNA. PCR technique is based on the natural processes a cell uses to replicate a new DNA strand. Five core ‘ingredients’ are required to set up a PCR i.e. the DNA template to be copied, primers, DNA nucleotide bases, Taq polymerase enzyme, and buffer. PCR involves a process of heating and cooling called thermal cycling which is carried out by a machine in three main stages Denaturing, Annealing and Extending. These three stages are repeated 20-40 times, doubling the number of DNA copies each time. After PCR has been completed, electrophoresis can be used to check the quantity and size of the DNA fragments produced. PCR is used in many areas of biology and medicine, including molecular biology research, medical diagnostics, and even some branches of ecology.
The Polymerase Chain Reaction market is anticipated to witness remarkable growth during the given forecast period. The growth in the market may be attributed to the rising use of polymerase chain reactions in clinical diagnostics and drug development. Technological advancements in PCR techniques will also positively impact the market during the given forecast period. However, the high cost of the instruments required for Polymerase chain reactions might hamper the growth of the market during the given time frame.
By Product Type
By product type, the global Polymerase Chain Reaction (PCR) Market is segmented into Reagents, Instruments, Consumables, and Software. The reagents section is expected to hold a significant share owing to the high consumption of the reagents and the availability of different types of tests that require multiple types of reagents. Rising innovation in the reagent specificity will also boost the market for the segment during the given forecast period.
By End Users
In terms of end-user, the global Polymerase Chain Reaction (PCR) market is segmented as Pharmaceuticals and Biopharmaceutical Companies, Diagnostic Labs, and Research Institutes. The pharmaceutical and biotechnology industry segment is expected to witness steady growth during the given time frame. The growth may be attributed to the continuous development in the pharmaceutical and biotechnology industries.
By Geography
Geographically, the Polymerase Chain Reaction (PCR) market is segmented as North America, South America, Europe, the Middle East and Africa, and Asia Pacific. North America accounted for a significant market share in 2018 due to the rising incidence of various types of cancer and metabolic diseases that demand advanced diagnosis and therapies. Early adoption of the technology in the region will also boost the adoption of PCR in the region. Asia Pacific is projected to witness the fastest regional market growth during the forecast period. Improved healthcare infrastructure and rising investment in healthcare and in life science research will fuel the growth of the PCR market in this region.
Segmentation
By Product Type
Reagents
Instruments
Consumables
Software & Services
By Technology
Conventional PCR
Real-Time PCR
Digital PCR
Others
By Application
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East & Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
South Korea
Taiwan
Others